ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Disease
Dust Mite Allergy

Asthma trials near Dallas, TX, USA:

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma (Polaris)

dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivot...

Enrolling
Asthma
Drug: Placebo
Drug: WIN378

Phase 2

Windward Bio

McKinney, Texas, United States and 72 other locations

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...

Enrolling
Severe Asthma
Drug: Placebo
Drug: GB-0895

Phase 3

Generate Biomedicines

Dallas, Texas, United States and 133 other locations

and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroi...

Enrolling
Asthma
Drug: ENV-294
Drug: Placebo

Phase 2

Enveda Therapeutics

McKinney, Texas, United States of America and 24 other locations

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Active, not recruiting
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

McKinney, Texas, United States and 65 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Dallas, Texas, United States and 335 other locations

This Phase 2b open-label, long-term extension study is designed to evaluate the long-term safety and efficacy of KT-621 in participants with asthma...

Enrolling
Asthma (Diagnosis)
Drug: KT-621

Phase 2

Kymera Therapeutics

Dallas, Texas, United States and 6 other locations

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...

Enrolling
Asthma
Biological: Depemokimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

McKinney, Texas, United States and 49 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Dallas, Texas, United States and 146 other locations

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting
Severe Asthma
Drug: Verekitug
Drug: Placebo

Phase 2

Upstream Bio

Dallas, Texas, United States of America and 101 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Dallas, Texas, United States and 137 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems